Personalized assessment of hyperuricemia probability in metabolic dysfunction-associated steatotic liver disease: construction and multicenter validation of a clinical nomogram
Abstract Background Metabolic dysfunction-associated steatotic liver disease is increasingly recognized as a precursor to secondary hyperuricemia, significantly exacerbating metabolic burden. However, reliable tools for early risk stratification in MASLD patients remain limited. This study aimed to...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-05-01
|
| Col·lecció: | BMC Gastroenterology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12876-026-04844-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
